ZIM
SCPH

Zacks Investment Management’s scPharmaceuticals SCPH Stock Holding History

Zacks Investment Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-32,416
Closed -$294K – 716
2023
Q1 		$294K Hold
32,416
– – ﹤0.01% 524
2022
Q4 		$232K Sell
32,416
-4,573
-12% -$27.9K ﹤0.01% 539
2022
Q3 		$241K Hold
36,989
– – ﹤0.01% 513
2022
Q2 		$178K Hold
36,989
– – ﹤0.01% 551
2022
Q1 		$210K Hold
36,989
– – ﹤0.01% 571
2021
Q4 		$186K Hold
36,989
– – ﹤0.01% 591
2021
Q3 		$246K Hold
36,989
– – ﹤0.01% 553
2021
Q2 		$226K Buy
+36,989
New +$223K ﹤0.01% 553
2021
Q1 		– Sell
-38,539
Closed -$204K – 573
2020
Q4 		$204K Buy
+38,539
New +$302K ﹤0.01% 500

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return